Alliance for a Stronger FDA says the vaccines development industry is likely to see a renaissance under pressure from the Covid-19 pandemic.
FDA grants Gilead Sciences an emergency use authorization for its antiviral drug remdesivir for treating suspected or laboratory-confirmed Covid-19 in...
Three stakeholders comment for the FDA docket on updating the agency data strategy.
CDER issues a MAPP on its approach to newly identified safety signals in marketed drugs.
Federal Register notice: FDA seeks comments on an information collection extension entitled Information Sharing Among Constituent Part Applicants 21 ...
Federal Register notice: FDA makes available a final guidance entitled Temporary Policy Regarding Accredited Third-Party Certification Program Onsite ...
Federal Register notice: FDA postpones a 6/9-planned Ophthalmic Devices Panel of the Medical Devices Advisory Committee meeting that was going to revi...
The Utah federal court orders two companies and their owner to stop selling silver products as a preventive or treatment for Covid-19.